SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001214659-05-001849
Filing Date
2005-12-21
Accepted
2005-12-21 11:24:06
Documents
1
Period of Report
2005-12-14

Document Format Files

Seq Description Document Type Size
1 f12252f3_ex.html 3  
1 f12252f3_ex.xml 3 3115
  Complete submission text file 0001214659-05-001849.txt   4918
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address RUBEN DARIO #223 5-A CHAPULTEPEC MORALES MEXICO D.F. O5 11570
Business Address 52554334556
Gonzalez Alejandro (Reporting) CIK: 0001313799 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-24274 | Film No.: 051277375